PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-744

Market over the past week has been extremely subdued ,, seems more and more retail money is leaving the ASX , Cost of living is biting with increased Interest Rates , Increased Insurances and Increased ,,,well everything ,,,, Just need PAA to get back to work ,,, The BOD spill although well worth the change for future value has dented any momentum, this Raise is taking time also , literally a month out the calendar for 2024?
The Commercially Run Tablets must be close to delivery? 1m Tablets wont be cheap..... and we don't want them to be either.... as long as they perform like the previous batches...
Funds will drop and the Trial will be registered?
Patient Recruitment can then begin , I don't see this as an issue as PAA has a very High Profile in Australia with Mathers and Rowe as the Principal Investigators who consult circa 40% of all MND cases in Australia..
The Clock is ticking ,,4C end of this month will only show a partial wage burn but we know our burn rate will have increased ,, Good People deserve Good Money...no issue there...

Data is where the value lays in Biotech and PAA need to generate some fresh new data to move the needle$$$

Does anyone know what the Name of our New Drug is? NZT